A blog about chemistry, drug development, science, and technology
Gilead and Merck will be distributing the new AIDS drug Atripla, a drug drug combination in a once-a-day pill, to developing countries.
Gilead, Merck to distribute combination AIDS pill | Reuters.com
One interesting fact is that the pills for developing countries are white whereas those for US and Europe are salmon colored. While this article doesn’t state why, it is most likely to prevent cheaper version from developing countries from make their way into the US and Europe.
The major take home fact here is that there is now a single, once-a-day pill which replaces a regime of taking dozens of pills and tablets at specified times through out the day. This is especially important in developing countries where obtaining drinking water is difficult. Also, not having to take the drugs on a schedule makes compliance much easier. It should be kept in mind that one of the most serious issues confronting AIDS is the virus developing resistance to known drugs.
Technorati Tags: aids drugs, HIV drugs
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 0.830 seconds